Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Insulin Degludec Vs. Insulin Glargine

Share Post:

What is insulin glargine?

Insulin glargine, also known by the brand name Lantus, is a long-lasting basal insulin analog that is taken once per day to help control blood sugar levels in those suffering from diabetes. It gradually secretes insulin, so its effects last between 18 and 26 hours. Its effects on the body are similar to those of basal insulin in non-diabetic pancreatic beta cells. It may also be used in combination with a fast-acting insulin.

What is insulin degludec?

Insulin degludec is an ultra-long-acting basal insulin analog that is approved for use in adults with type 1 and type 2 diabetes. It is administered by injection once per day to help control the blood sugar levels of those with diabetes. The effects of insulin degludec last up to 42 hours. This insulin is also marketed under the name Tresiba.

Differences and similarities between insulin glargine and insulin degludec

Differences

Tresiba, although a popular insulin, was only released back in 2016. Lantus, on the other hand, was released in 2000. While Tresiba is also slightly more expensive compared to Lantus, it is also 50% less likely to cause hypoglycemia. Compared to insulin glargine, insulin degludec also proved to be more predictable in controlling blood sugar. Insulin glargine, however, can lower A1c by up to 2 to 3%. Lantus is also considered safe for use in people with kidney or liver problems.

Similarities

Both insulin medications may cause slight weight gain. Both Lantus and Tresiba are injectable drugs and you must monitor your blood sugar regularly. Dosing with either medication is easy to customize and should be taken once daily.


Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.
Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on May 5, 2022

Related Articles

Diabetes, Diabetes Supplies,
What Determines Basaglar Insulin Price? Key Factors You Need to Know

Summary: The Basaglar insulin price is shaped by production complexity, regulatory costs, and market competition. Insurance coverage, PBMs, and economic factors also affect the final cost. Recognizing these elements can…

Read More
Diabetes, Diabetes Supplies,
Is There a Basaglar Generic Name? A Guide to Insulin Alternatives

Summary: For individuals managing diabetes, understanding insulin options and their potential generic equivalents is essential. This guide explains Basaglar generic name and comparable insulin alternatives, helping patients make informed choices…

Read More
Diabetes, Diabetes Supplies,
Managing Basaglar Side Effects: Best Practices for a Safer Insulin Experience

Summary: Managing Basaglar side effects is essential for safe, effective treatment. Following a few best practices, such as understanding potential reactions, keeping track of symptoms, and consulting healthcare providers, can…

Read More
Diabetes, Diabetes Supplies,
Save More with a Basaglar Coupon: Tips for Lowering Insulin Costs

Summary: A Basaglar coupon can significantly lower the cost of this long-acting insulin for individuals managing diabetes. By using savings programs, digital coupons, or exploring other discount options, you can…

Read More